Slit diaphragm of glomerular filtration. Diagnostic and therapeutic approach in nephrotic syndrome;El diafragma de filtración glomerular. Orientación diagnóstica y terapéutica en el síndrome nefrótico

Nefrologia

Volumn 25, Issue 4, 2005, Pages 361-368

  Arrizabalaga, Pilar ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; NEPHRIN; PODOCIN; SIGNAL PEPTIDE;

ADULT; AGE; ANIMAL; BASEMENT MEMBRANE; CHILD; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; GLOMERULUS; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KIDNEY DISEASE; METABOLISM; MUTATION; NEPHROTIC SYNDROME; PHYSIOLOGY; PROTEINURIA; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; WESTERN BLOTTING;

ADULT; AGE FACTORS; ANIMALS; BASEMENT MEMBRANE; BLOTTING, WESTERN; CHILD; DIAGNOSIS, DIFFERENTIAL; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MEMBRANE PROTEINS; MUTATION; NEPHROTIC SYNDROME; PROTEINURIA; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 27744607113     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. th edición. WB Saunders Co, Philadelphia, pp. 8-12, 2004.
2. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K: Positionally cloned gene for a novel glomerular protein-nehrin-is mutated in congenital nephrotic sundrome. Moll Cell 1: 575-82, 1998.
3. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistent nephrotic syndrome. Nature Genet 24: 349-54, 2000.
4. Meyrier A: Nephrotic focal segmental glomerulosclerosis in 2004: an update. Nephrol Dial Transplant 19: 2437-44, 2004.
5. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mathis BJ, Rodríguez-Pérez JC, Allen PG, Beggs AH, Pollak MR: Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis. Nature Genet 24: 251-6, 2000.
6. Yang Y, Jeanpierre C, Dressler GR, Lacoste M, Niaudet P, Gubler MC: WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis. Am J Pathol 154: 181-192, 1999.
7. Asanuma K, Mundel P: The role of podocytes in glomerular pathobiology. Clin Exp Nephrol 7: 255-9, 2003.
8. Kretzler M: Regulation of adhesive interaction between podocytes and glomerular basement membrane. Microsc Res Tech 57: 247-53, 2002.
9. Ruotsalainen V, Ljungberg P, Wartiovaara J, Lenkkeri U, Kestila M, Jalanko H, Holmberg C, Tryggvason K: Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci USA 96: 7962-67, 1999.
10. Holzman LB, St John PL, Kovari IA, Verma R, Holthofer H, Abrahamson DR: Nephrin localizes to the slit pore of the glomerular epithelial cell. Kidney Int 56: 1481-91, 1999.
11. Putaala H, Soininen R, Kilpeläinen P, Wartiovaara J, Tryggvason K: The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 10: 1-8, 2001.
12. Roselli S, Gribouval O, Boute N, Sich M, Benessy F, Attie T, Gubler MC, Antignac C: Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 160: 131-9, 2002.
13. Srichai MB, Konieczkowski M, Padiyar A, Konieczkowski DJ, Mukherjee A, Hayden PS, Kamat S, Ashraf El-Meanawy M, Khan S, Mundel P, Lee SB, Bruggeman LA, Schelling JR, Sedor JR: A WT1 co-regulator controls podocyte phenotype by shuttling between adhesion structures and nucleus. J Biol Chem 279: 14398-408, 2004.
14. Kerjaschki D, Sharkey DJ, Farquhar MG: Identification and characterization of podocalyxin-the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol 98: 1591-6, 1984.
15. Ostalska D, Zachwieja J, Siwinska A, Nowicki M, Witt M, Zaniew M: Reorganisation of podocyte cytoskeleton in proteinuric and steroid-resistant glomerular diseases in children: an immunohistochemistry approach. XXXXI Congress of the EDTA, Lisbone. p. 239, 2004.
16. Pavenstädt H: Roles of the podocyte in glomerular function. Am J Physiol Renal Physiol 278: F173-9, 2000.
17. Barisoni L, Kriz W, Mundel P, D'Agati V: The dysregulated podocyte phenotype. A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10: 51-6, 1999.
18. Regele HM, Fillipovic E, Langer B, Poczewki H, Kraxberger I, Bittner RE, Kerjaschi D. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis. J Am Soc Nephrol 11: 403-12, 2000.
19. Shikata K, Makino H, Morioka S, Kashitani T, Hirata K, Ota Z, Wada J, Kanwar YS: Distribution of extracellular matrix receptors in various forms of glomerulonephritis. Am J Kidney Dis 25: 680-8, 1995.
20. Topham PS, Haydar SA, Kuphal R, Lightfoot JD, Salant DJ: Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions. Kidney Int 55: 1763-75, 1999.
21. Steffes MW, Schmidt D, McCrery R, Basgen JM, International Diabetic Nephropatic Study Group: Glomerular cell number in normal subjects and in type I diabetic patients. Kidney Int 59: 2104-13, 2001.
22. Matsui K, Breitender-Geleff S, Soleiman A, Kowalski H, Kerjaschki D: Podoplanin, novel 43-kd membrane protein, controls the shape of podocytes. Nephrol Dial Transplant 14 (Supl. 1): 9-11, 1999.
23. Topham PS, Kawachi H, Haydar SA, Chugh S, Addona TA, Charron KB, Holzman LB, Shia M, Shimizu F, Salant DJ: Nephritogenic mAb 5-1-6 is directed at the extracelular domain of rat nephrin. J Clin Invest 104: 1559-66, 1999.
24. Wang SX, Ahola H, Palmen T, Solin ML, Luimula P, Holthofer H: Recurrence of nephrotic syndrome after transplantation in CNF is due to autoantibodies to nephrin. Exp Nephrol 9: 327-31, 2001.
25. Benigni A, Tomasoni S, Gagliardini E, Zoja C, Grunkemeyer JA, Kalluri R, Remuzzi G: Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol 12: 941-8, 2001.
26. Yuan H, Takeuchi E, Taylor GA, McLaughlin M, Brown D, Salant DJ: Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy. J Am Soc Nephrol 13: 946-56, 2002.
27. Nakatsue T, Koike H, Han GH, Suzuki K, Yuan H, Salant DJ, Gejyo F, Shimizu F, Kawachi H: Nephrin is dissociated from podocin in experimental membranous nephropathy. J Am Soc Nephrol 14: 166A, 2003.
28. Suzuki K, Koike H, Han GH, Nakatsue T, Shimizu F, Kawachi H: Angiotensin II receptor antagonist prevents the reduction of nephrin expression and attenuates proteinuria in antinephrin monoclonal antibody 5-1-6 induced nephropathy. J Am Soc Nephrol 14: 160A, 2003.
29. Blanco S, Bonet J, López D, Casas I, Romero R: ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosis. Kidney Int (Supl. 93): S10-S14, 2005.
30. Lahdenkari AT, Lounatmaa K, Patrakka J, Holmberg C, Wartiovaara J, Kestila M, Koskimies O, Jalanko H: Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria. J Am Soc Nephrol 15: 2611-8, 2004.
31. Furness PN, Hall LL, Shaw JA, Pringle JH: Glomerular expression of nephrin is decreased in acquired human nephrotic syndrome. Nephrol Dial Transplant 14: 1234-37, 1999.
32. Doublier S, Ruotsalainen V, Salvidio G, Lupia E, Biancone L, Conaldi PG, Reponen P, Tryggvason K, Camussi G: Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol 158: 1723-31, 2001.
33. Rantanen M, Palmen T, Patari A, Ahola H, Lehtonen S, Astrom E, Floss T, Vauti F, Wurst W, Ruiz P, Kerjaschki D, Holthofer H: Nephrin TRAP mice lack slit diaphragms and show fibrotic glomeruli and cystic tubular lesions. J Am Soc Nephrol 13: 1586-94, 2002.
34. Doublier S, Salvidio G, Lupia E, Ruotsalainen V, Verzola D, Deferrari G, Camussi G: Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 52: 1023-30, 2003.
35. Patari A, Forsblom C, Havana M, Taipale H, Group PH, Holthofer H: Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes 52: 2969-74, 2003.
36. Patrakka J, Routsalainen V, Ketola I, Holmberg C, Heikinheimo M, Tryggvason K, Jalanko H: Expression of nephrin in pediatric kidney diseases. J Am Soc Nephrol 12; 289-296, 2001.
37. Huh W, Kim DJ, Kim MK, Kim YG, Oh HY, Ruotsalainen V, Tryggvason K: Expression of nephrin in acquired human glomerular disease. Nephrol Dial Transplant 17: 478-84, 2002.
38. Koop K, Eikmans M, Baelde HJ, Kawachi H, De Heer E, Paul LC, Bruijn JA: Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol 14: 2063-71, 2003.
39. Schmid H, Henger A, Cohen CD, Frach K, Grone HJ, Schlondorff D, Kretzler M: Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol 14: 2958-66, 2003.
40. Horinouchi I, Nakazato H, Kawano T, Iyama K, Furuse A, Arizono K, Machida J, Sakamoto T, Endo F, Hattori S: In situ evaluation of podocin in normal and glomerular diseases. Kidney Int 64: 2092-9, 2003.
41. Shih NY, Li J, Karpitskii V, Nguyen A, Dustin ML, Kanagawa O, Miner JH, Shaw AS: Congenital nephrotic sundrome in mice lacking CD2-associated protein. Science 286: 312-5, 1999.
42. Kim JM, Wu H, Green G, Winkler CA, Kopp JB, Miner JH, Unanue ER, Shaw AS: CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300: 1298-300, 2003.
43. Van Den Berg JG, Weening JJ: Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clinical Science 107: 125-36, 2004.
44. Kawanishi H, Prassun KD, Gross EJ, Kapoian T, Lianos E: Wilms tumor 1 (WT1) expression in glomerular epithelial cell injury (GEC). J Am Soc Nephrol 14: 156A, 2003.
45. Ruf RG, Schultheiss M, Lichtenberger A, Karle SM, Zalewski I, Mucha B, Everding AS, Neuhaus T, Patzer L, Plank C, Haas JP, Ozaltin F, Imm A, Fuchshuber A, Bakkaloglu A, Hildebrandt F, APN Study Group: Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. Kidney Int 66: 564-70, 2004.